ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan

ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan

Otsuka Pharmaceutical Co., Ltd. today obtained regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for ABILIFY as the first antsipsychotic drug in Japan to treat...

http://japan.pharmaintellect.com/2013/06/abilify-granted-additional-approval-as.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+Pharmainvest+%28PharmaInvest%29